🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07530354
Recruiting Observational

A Longitudinal Cohort Study on the Changes of Physiological Mechanisms in Children After Biliary Tract Reconstruction

NCT07530354 · tracked via the Priya Life Science China tracker
Sponsor
Wuhan Children's Hospital
Phase
Observational
Started
2025-05-01
Last updated
2026-04-15

Condition(s) studied

Choledochal Cyst

Study summary

Through observational studies, the long-term changes in liver function, metabolic state, immune response and other aspects of children after biliary tract reconstruction during their growth process were systematically explored. The risks of these long-term physiological changes on chronic diseases such as cardiovascular diseases, diabetic diseases and liver cirrhosis in adulthood, as well as their impacts on cognitive function, musculoskeletal health and other aspects were evaluated. How do early physiological changes affect a patient's long-term health? Are there any potential biomarkers that can predict future health outcomes? Based on the research results, preventive and intervention measures that are helpful in reducing the risk of long-term complications are proposed.

Eligibility

Sex
ALL
Min age
Max age
16 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy children matched by age and gender were selected as the control group Exclusion Criteria: * Combined with other serious diseases (such as cancer, autoimmune diseases), having obvious liver function abnormalities before surgery or being undergoing other major treatments.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Wuhan Children's Hospital Wuhan Hubei Recruiting
Wuhan Children'S Hospital Wuhan Hubei Recruiting
Wuhan Children'S Hospital Wuhan Hubei Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07530354 on ClinicalTrials.gov ↗ ← All trials in China